Basic information

Biomarker: NAV2

Histology type: endometrial stromal tumor

Stage: low grade

Cohort characteristics

Country: Norway

Region: Oslo

Study type: retrospective study

Followed up time :

Subgroup 1 name : LMS

Subgroup 1 number: 171

Subgroup 2 name: LG-ESS

Subgroup 2 number: 74

Total number Group I Group I number Group II Group II number Group III Group III number Group IV Group IV number
305 uterine leiomyosarcoma 231 low-grade endometrial stromal sarcomas 74

Sample information

Conclusion: NAV2 are novel candidate prognostic markers in LG-ESS.

Sample type : tissue

Sample method: immunohistochemistry

Expression pattern : expression

Expression elevation: IHC scoring: Staining extent and intensity were scored separately by two surgical pathologists (BK and BD). Tumors were scored as negative (0% stained cells), focally positive (1–10% stained cells), moderately positive (11–50% stained cells), or diffusely positive (staining in >50% cells),corresponding to a score of 0–3.

Disease information

Statictics: Median;Range

Cohort age: 57;20-90

Related information

Funtion Uniprot: Possesses 3' to 5' helicase activity and exonuclease activity. Involved in neuronal development, specifically in the development of different sensory organs.

UniProt ID: Q8IVL1

UniProt Link: https://www.uniprot.org/uniprotkb/Q8IVL1/entry

Molecular function from UniProt:

Tissue specificity from UniProt: Highly expressed in the brain, kidney and liver. Also expressed in the thyroid, mammary gland, spinal cord, heart, placenta and lung. Abundantly expressed in colon cancers.

Subcellular UniProt: #Nucleus

Alternative name from UniProt:

Catalytic activity: ATP + H2O = ADP + H+ + phosphate

Gene name from HGNC: NAV2 (FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1)

Induction: By all-trans retinoic acid (ATRA). Up-regulated in colorectal carcinomas.

HPA link: https://www.proteinatlas.org/ENSG00000166833-NAV2

Tissue specificity RNA from HPA: Tissue enhanced (brain, heart muscle)

Tissue expression from HPA: Cytoplasmic expression at variable levels in most tissues.

Subcellular summary HPA Located in Nucleoplasm

Cancer prognostic summary HPA Gene product is not prognostic

Pathology link: https://www.proteinatlas.org/ENSG00000166833-NAV2/tissue

Pathology endo: https://www.proteinatlas.org/ENSG00000166833-NAV2/tissue/duodenum

OMIM: 607026

OMIM link2: https://www.omim.org/entry/607026#title

HGNC ID: HGNC:15997

HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:15997

Visulization